Inactive Instrument

Other languages GENB AS Other OTC

Equities

US3723032062

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study	06-03
Genmab Announces Initial Data from Phase 2 Cancer Treatment Trial	06-03
Genmab A/S Announces New Efficacy and Safety Data from Two Ongoing Phase 1/2 Clinical Trials Evaluating Epcoritamab, A T-Cell Engaging Bispecific Antibody Administered Subcutaneously, in Adult Patients with Certain Types of Follicular Lymphoma	06-02
Genmab A/S and Biontech SE Announce Initial Data from the Phase 2 Gct1046-04 Trial (NCT05117242) Evaluating Acasunlimab	06-01
Genmab A/S Reaffirms Financial Guidance for 2024	05-21
Genmab A/S completed the acquisition of ProfoundBio, Inc.	05-20
Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'	05-15
Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50%	05-15
Genmab A/S to Present New and Updated Results from Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies At the 2024 European Hematology Association Congress	05-14
OPINIONI DEGLI ANALISTI DEL GIORNO : Italgas, Amplifon, Enel, BBVA, Aperam, Safran, Santander, Pandora, Amadeus It, Lonza, ASM International...	05-07
AVIS D'ANALYSTES DU JOUR : Thales, Safran, Schneider, Ubisoft, Pandora, Lonza, ASM International...	05-07
OPINIONES DE LOS ANALISTAS DEL DÍA : ACS, Vidrala, Indra Sistemas, Enagás, BBVA, Santander, Pandora, Amadeus It, Lonza, ASM International...	05-07
OPINIONI DEGLI ANALISTI DEL GIORNO : ACS, Safran, Santander, Endesa, Amadeus It, Telefónica, Aena, Cellnex, Sixt, JCDecaux...	05-06
AVIS D'ANALYSTES DU JOUR : Crédit Agricole, Safran, Société Générale, Vinci, Air France, Cellnex, JCDecaux...	05-06
OPINIONES DE LOS ANALISTAS DEL DÍA : ACS, Safran, Santander, Endesa, Amadeus It, Telefónica, Aena, Cellnex, Sixt, JCDecaux...	05-06
GENMAB : A good start to 2024; guidance unchanged	05-03
Aggiornamento sui forti movimenti della giornata: Banks, Genmab, Daimler Truck ... risultati riassunti qui!	05-03
Actualización de las fuertes variaciones del día: Bancos, Genmab, Daimler Truck ... ¡resultados resumidos aquí!	05-03
Les actions en mouvement : Les banques, JCDecaux, Bonduelle ... les publications de résultats résumées ici !	05-03
Genmab Posts Q1 Net Profit Surge; Revenue Jumps	05-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm